¶ Biomedical Advanced Research and Development Authority
.png)
The Biomedical Advanced Research and Development Authority (BARDA) is an American federal government agency responsible for the procurement and development of medical countermeasures. Its areas of focus include defending against chemical, biological, radiological and nuclear threats, as well as infectious diseases and pandemic preparedness.[1]
BARDA reports to the Administration for Strategic Preparedness and Response (ASPR) within the United States Department of Health and Human Services (HHS).
¶ History
On September 15, 2011, BARDA awarded a $21 million contract to Vaxin (now called Altimmune)[2] to develop a novel anthrax vaccine.[3] Robert Malone claims credit for securing this grant.[4]
¶ COVID-19
On April 14, 2020, BARDA awarded Alchem Laboratories a $20.7 million contract to conduct a clinical trial on famotidine as a potential treatment for COVID-19.[5]
At some point in 2020, Steve Kirsch reached out to Robert Malone for help applying for an Emergency Use Authorization (EUA) from BARDA.[6]
¶ Organization
BARDA is a partner organization of Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV).[7]
¶ Activities
BARDA has provided notable funding to:
- ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications[8]
- Johns Hopkins Center for Health Security[9]
- National COVID Cohort Collaborative[10]
¶ External links
Kraft, M., & Marks, E. (2011). U.S. Government Counterterrorism: A Guide to Who Does What (p. 140). CRC Press. https://amzn.to/3rfESMm ↩︎
Enright, B. (2015, September 1). Vaxin Changes Company Name To Altimmune. Altimmune. https://web.archive.org/web/20230621185625/https://ir.altimmune.com/news-releases/news-release-details/vaxin-changes-company-name-altimmune ↩︎
Novel anthrax vaccine being developed with BARDA support. (2020, August 5). Public Health Emergency; Assistant Secretary for Preparedness and Response. http://archive.today/2023.06.21-185030/https://www.phe.gov/Preparedness/mcm/Pages/novel-anthrax-110915.aspx ↩︎
Malone, R. W. (2017, March). RWM CV. Squarespace. https://web.archive.org/web/20230119104151/https://static1.squarespace.com/static/550b0ac4e4b0c16cdea1b084/t/58e5406b5016e1f1acacae75/1491419246742/RWM+CV+March+2017.pdf ↩︎
Borrell, B. (2020). New York clinical trial quietly tests heartburn remedy against coronavirus. Science. https://doi.org/10.1126/science.abc4739 ↩︎
Vaccine Safety Research Foundation. (2023, January 26). Full Episode #64: “Defeat the Mandates Anniversary” with Robert Malone, MD. Rumble. https://web.archive.org/web/20230222180536/https://rumble.com/v27aicu-full-episode-64-defeat-the-mandates-anniversary-with-robert-malone-md.html ↩︎
ACTIV. National Institutes of Health (NIH). Retrieved April 1, 2022, from http://archive.today/2022.01.11-042823/https://www.nih.gov/research-training/medical-research-initiatives/activ ↩︎
Naggie, S., Boulware, D. R., Lindsell, C. J., Stewart, T. G., Slandzicki, A. J., Lim, S. C., Cohen, J., Kavtaradze, D., Amon, A. P., Gabriel, A., Gentile, N., Felker, G. M., Jayaweera, D., McCarthy, M. W., Sulkowski, M., Rothman, R. L., Wilson, S., DeLong, A., Remaly, A., & Wilder, R. (2023). Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial. JAMA, 329(11), 888-897. https://doi.org/10.1001/jama.2023.1650 ↩︎
Completed Projects. Johns Hopkins Center for Health Security. Retrieved July 11, 2023, from https://web.archive.org/web/20230711201855/https://centerforhealthsecurity.org/our-work/research-projects/completed-projects ↩︎
Funded activities under the NCATS Clinical and Translational Science Awards (CTSA) Program with NCATS’ Appropriation and Additional CTSA Funding from Other Sources. (2024, April). National Center for Advancing Translational Sciences. https://web.archive.org/web/20240601233251/https://ncats.nih.gov/sites/default/files/2024-04/CTSA-Program-Funded-Activities-and-Other-Sources-Final-FY23_508.pdf ↩︎